Results 31 to 40 of about 491,575 (216)

Epididymitis following Cytoreductive Surgery with Intraperitoneal Oxaliplatin Chemotherapy: Two Case Reports

Case Reports in Oncology, 2016
Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy has emerged as an aggressive treatment option with intent to either cure or extend disease-free survival of selected patients with peritoneal carcinomatosis.
Luiza Damian Ribeiro Barbosa, Marcos Belotto, Renata D'Alpino Peixoto   +2 more
doaj   +1 more source

The Role of Hyperthermic Intraperitoneal Chemotherapy in Uterine Cancer Therapy

, 2023
Endometrial cancer and uterine sarcoma represent the two major types of uterine cancer. In advanced stages, both cancer entities are challenging to treat and correlate with a meagre survival and prognosis. Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Sarantis, Panagiotis, Kouraklis, Gregory, Vrettou, Kleio, Antoniou, Efstathios A., Psilopatis, Iason, Dimitroulis, Dimitrios, Koustas, Evangelos, Chionis, Athanasios, Damaskos, Christos, Kontzoglou, Konstantinos, Garmpis, Nikolaos, Garmpi, Anna   +11 more
core   +2 more sources

Hyperthermic Intraperitoneal Chemotherapy for Recurrent Nephroblastoma in Children

Journal of the College of Physicians and Surgeons Pakistan, 2023
For children with recurrent nephroblastoma, intraoperative HIPEC has little impact on the body, can significantly improve the effectiveness and reduce the recurrence rate, and does not increase the adverse reactions.Children, Recurrence, Nephroblastoma, Hyperthermic perfusion.Sixty children with recurrent nephroblastoma treated by HIPEC in the ...
Jia-Rong, Wang, de-Guang, Meng, Ya-Nan, Hu, Na, Wang, Huan-Min, Wang, Huai-da, Teng   +5 more
openaire   +2 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) [PDF]

, 2013
Hemmer PHJ, Van Leeuwen BL. Hyperthermic intraperitoneal chemotherapy (HIPEC). Huisarts Wet 2013;56(1):36-9.Surgery forms the basis of cancer therapy, and surgical resection sometimes improves survival in metastatic disease. One such surgical approach is
Hemmer, Patrick, Van Leeuwen, Barbara; id_orcid   +1 more
core   +1 more source

Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy [PDF]

, 2021
Cisplatin is one of the most widely used chemotherapeutic agents in oncology, although its nephrotoxicity limits application and dosage. We present the results of a clinical study on prophylaxis of cisplatin-induced nephrotoxicity in patients with ...
Vasquez-Jimenez, Wenceslao, Canal Alonso, María Iluminada, Canal-Alonso, María Iluminada, Pilar Cabrerizo-Torrente, Ginel-Feito, María Dolores, María Dolores Ginel-Feito, Palencia-García, Natividad, Lozano-Lominchar, Pablo, González Nicolás González, María Ángeles, Lázaro Fernández, Alberto, Mercedes Power, Consuelo Jiménez, Palencia García, Natividad, Matilde Zaballos, Zaballos, Matilde, Natividad Palencia-García, González-Bayón, Luis, Vasquez Jimenez, Wenceslao, Gago Quiroga, Susana, María Ángeles González-Nicolás, Alberto Lázaro, María Iluminada Canal-Alonso, Jiménez, Consuelo, Susana Gago-Quiroga, Pablo Lozano-Lominchar, González Bayón, Luis, Zaballos García, Matilde, Wenceslao Vasquez-Jimenez, Lázaro, Alberto, Gago-Quiroga, Susana, Luis González-Bayón, Ginel Feito, María Dolores, Power, Mercedes, González-Nicolás, María Ángeles, Cabrerizo-Torrente, Pilar, Cabrerizo Torrente, Pilar, Lozano Lominchar, Pablo   +36 more
core   +1 more source

Optimising postoperative care after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

Advances in Perioperative Care
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy is an aggressive, but increasingly utilised, treatment for advanced peritoneal malignancy.
Laoise Niamh Geoghegan
doaj   +2 more sources

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy

Frontiers in Oncology, 2021
Background: To identify the maximum tolerated dose (MTD) of hyperthermic intraperitoneal cisplatin at 43°C among gynecological cancer patients.Methods: In this Phase I dose-finding trial, Bayesian optimal interval (BOIN) design was used.
Chui-ying Chan, Hui Li, Miao-fang Wu, Chang-hao Liu, Huai-wu Lu, Zhong-qiu Lin, Jing Li   +6 more
doaj   +1 more source

Hyperthermic Intraperitoneal Chemotherapy in Ephitelial Ovarian Cancer should be proposed in eight time points.

, 2014
Comment in Response to: "hyperthermic intraperitoneal chemotherapy in epithelial ovarian cancer should be proposed in eight time points". [Eur J Surg Oncol. 2014] Comment on Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic
DE IACO, PIERANDREA, ZAMAGNI, CLAUDIO, PERRONE, ANNA MYRIAM   +2 more
core   +1 more source

The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer [PDF]

Indian Journal of Surgical Oncology, 2016
Peritoneal metastasis, either synchronous or metachronous, is commonly seen in gastric cancer. It is associated with a poor prognosis, with a median survival of less than one year. The outcomes are not significantly improved by the use of systemic chemotherapy. We review the relevant literature on the role of HIPEC in gastric cancer.
Ramakrishnan Ayloor, Seshadri, Olivier, Glehen   +1 more
openaire   +2 more sources

Simulating drug penetration during hyperthermic intraperitoneal chemotherapy

Drug Delivery, 2021
Hyperthermic intraperitoneal chemotherapy (HIPEC) is administered to treat residual microscopic disease after debulking cytoreductive surgery. During HIPEC, a limited number of catheters are used to administer and drain fluid containing chemotherapy (41 ...
Daan R. Löke, Roxan F. C. P. A. Helderman, Nicolaas A. P. Franken, Arlene L. Oei, Pieter J. Tanis, Johannes Crezee, H. Petra Kok   +6 more
doaj   +1 more source